Pure Biologics establishes Doto Medical special purpose vehicle

2 December

2022

Pure Biologics establishes Doto Medical special purpose vehicle

Pure Biologics establishes the Doto Medical special purpose vehicle and signs an agreement with the renowned international business advisor Clairfield Partners to accelerate the commercialization of the PB103 aptamer project.

Recommendations for the Pure Biologics company shares

26 May

2021

Recommendations for the Pure Biologics company shares

Dom Maklerski BOŚ recommends the purchase of Pure Biologics shares.

Pure Biologics teams up with Twist Bioscience

15 April

2021

Pure Biologics teams up with Twist Bioscience

Pure Biologics joins efforts with Twist Bioscience to expand the capabilities of the phage display technology used in Pure Biologics' portfolio of immuno-oncology projects.

Project PB002 – preclinical research partner selected

19 March

2021

Project PB002 – preclinical research partner selected

Pure Biologics has selected a partner to lead the first panel of preclinical studies in the PB002 aptamer project

W poszukiwaniu nowych leków i przełomowych terapii – article in “Rzeczpospolita”

3 March

2021

W poszukiwaniu nowych leków i przełomowych terapii – article in “Rzeczpospolita”

An article presenting global trends in pharmaceutical R&D and how Polish companies fit into them.

European patent for modified aptamers (PB012 PureApta)

9 February

2021

European patent for modified aptamers (PB012 PureApta)

The European Patent Office issued a decision on granting a European patent for PureApta elements.

1
2
3
4
5
6
7
8
9

9 October

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/5/20 09.10.2020

17 June

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/4/20 17.06.2020

10 April

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/3/20 10.04.2020

25 January

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/2/20 25.01.2020

21 January

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/1/20 21.01.2020

1
2

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.